Skip to content

Clinical trial of the "Zhibian(BL54)to Shuidao(ST28)" manipulationon in postoperative pain management for patients with mixed hemorrhoids

Clinical trial of the "Zhibian(BL54)to Shuidao(ST28)" manipulationon in postoperative pain management for patients with mixed hemorrhoids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081302
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-15
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain of mixed hemorrhoids

Interventions

Acupuncture group:On the basis of the acupuncture therapy of "Zhibian(BL54)to Shuidao(ST28)" manipulationon, the patients in the control group were treated. (if the patient had postoperative pain and
Control group:The patients were given diclofenac double-release enteric-coated capsules, 75 mg of sodium diclofenac double-release enteric-coated capsules, =150 mg for 24 hours, if the patients had po

Sponsors

the affilinated Acunpuncture and Tuina hospital of Shanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients who met the diagnostic criteria of mixed hemorrhoids and had a VAS score =4; (2) Age 18-65 years old, both male and female; (3) Surgical anesthesia is lumbar-hard combined anesthesia; (4) The surgical procedure is external stripping and internal ligation of mixed hemorrhoids, and the surgical operation and dressing change are performed by the same person; (5) Regular diet, normal sleep, and previous physical fitness; (6) Those who voluntarily participate in the study and sign the informed consent form, with good compliance and willing to cooperate with observation and treatment.

Exclusion criteria

Exclusion criteria: (1) Patients receiving other treatments that affect the observational index of this subject; (2) Suffering from other rectal-anal diseases, such as perianal abscess, anal fistula, anal fissure and so on; (3) Patients with abnormalities seen in blood routine, urine routine, stool routine, coagulation, liver and kidney function, electrocardiogram and so on; (4) Patients with serious heart, liver, lung, kidney and other systemic diseases and mental anomalies; (5) Pregnant or lactating women; (6) Patients with infectious diseases such as hepatitis B and tuberculosis; (7) Local skin presence of skin infection or skin disease, not suitable for acupuncture; (8) Patients with previous allergic reactions to diclofenac sodium double-release enteric capsules; (9) Patients who are also participating in other clinical studies. Note: Patients who met any of the above were excluded.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Use of painkillers;Occurrence of postoperative complications;Side effects of pain medications;Quality of Life Scale (QLQ-C30);Duration of pain;

Countries

China

Contacts

Public ContactHaijun Wang

the affilinated Acunpuncture and Tuina hospital of Shanxi University of Chinese Medicine

whjdavid@163.com+86 158 0340 9395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026